Announcements Trials
Browse Landscape

Phase

Phase 1 25Phase 2 14Phase 1/2 8Phase 3 7Phase 2/3 2Phase NA 1Phase 4 1

Status

Unknown 3Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2NIH 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 225Head & Neck 144Gastrointestinal 126Gynecologic 95Genitourinary 48CNS 25Lymphoid 13Breast 9Tumor-Agnostic 7Other solid neoplasm 7Sarcoma 5Plasma cell 5Dermatologic 5Endocrine 3Other hematologic neoplasm 2Classical hematology 2Other neoplasm 1Other 1

Conditions

Carcinoma 3Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Metastasis 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Carboplatin 8Paclitaxel 7Fluorouracil 7Cisplatin 7atezolizumab 5Trastuzumab 5Pemetrexed 5Oxaliplatin 5Leucovorin 5Bevacizumab 5pembrolizumab 4Gemcitabine 4Capecitabine 4Albumin-Bound Paclitaxel 4Surveys and Questionnaires 3Observation 3Leuprolide 3Irinotecan 3Glutamine 3Drug Therapy 3Docetaxel 3Dexamethasone 3130-nm albumin-bound paclitaxel 3trifluridine tipiracil drug combination 2regorafenib 2osimertinib 2enzalutamide 2Surgical Procedures, Operative 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Cisplatin × Tumor-Agnostic × Clear all
NCT05261399 2026-04-06

SAFFRON

AstraZeneca

Phase 3 Active not recruiting
345 enrolled
Tumor-Agnostic

Carcinoma, Neoplasm Metastasis

NCT01855451 2022-11-18

HPVOropharynx

Trans Tasman Radiation Oncology Group

Phase 3 Unknown
189 enrolled
Tumor-Agnostic

Carcinoma

NCT04217512 2020-01-03

Pantoprazole in Cisplatin Nephrotoxicity

Tanta University

Phase 3 Recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT00548548 2017-06-14

AVAGAST

Genentech, Inc.

Phase 3 Completed
774 enrolled 14 charts
Tumor-Agnostic

Adenocarcinoma

NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

National Cancer Institute (NCI)

Phase 3 Unknown
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00126269 2006-09-08

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown
192 enrolled
Tumor-Agnostic

Carcinoma

NCT00201383 2005-09-20

Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

National Health Research Institutes, Taiwan

Phase 3 Completed
161 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡